Compare iShares MSCI United Kingdom (FTSE) (EWU) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI United Kingdom (FTSE) vs GE HealthCare Technologies Inc. Common Stock — how do they compare? iShares MSCI United Kingdom (FTSE) trades at $46.91 (market cap $3.71B), while GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 8.3× iShares MSCI United Kingdom (FTSE)'s market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares MSCI United Kingdom (FTSE) pays none. Which is the better fit depends on your goals.
| EWU | GEHC | |
|---|---|---|
Market Cap | $3.71B | $30.93B |
Volume | 728,527 | 5,033,451 |
Sector | Broad Market / Factor | Health |
52-Week High | $49.39 | $88.16 |
52-Week Low | $41.34 | $59.48 |
Typical Hold Time | 48 Days | — |
Enterprise Value | — | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWU trades at $46.82 with a modest 0.26% daily gain, though technical indicators signal bearish momentum with moving averages and overall signals pointing downward. The stock faces headwinds from UK economic concerns including rising gilt yields and inflation pressures. Recent news highlights volatility in UK markets, particularly affecting banking and housing sectors, creating a challenging environment for this UK-focused ETF.
The outlook remains cautious as rising UK borrowing costs and persistent inflation create macroeconomic headwinds. While housebuilder stocks have shown recent strength on government support programs, broader market sentiment is weighed down by energy price shocks and ECB rate hikes affecting European markets.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI United Kingdom (FTSE)
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
